ATS 2024 Final Program

Click on the session title to view the speakers

342

WEDNESDAY • MAY 22

508 Potentially Avoidable Healthcare Costs Associated With Delayed Diagnosis of Fibrotic Interstitial Lung Disease (ILD) 509 Validation of a Dyspnea Visual Analogue Scale in Fibrotic Interstitial Lung Disease 510 Patient Journey, Disease Burden and Treatment Paradigms in Patients With Interstitial Lung Disease With Progressive Pulmonary Fibrosis in Europe: A Cross-sectional Survey 511 Determinants of Pulmonary Referral for Patients With an ICD Diagnosis of Idiopathic Pulmonary Fibrosis or Unclassified Interstitial Lung Disease in an Academic Medical Center 512 Use of Weight Management Regimens Among Positive Airway Pressure-Treated Patients With Obstructive Sleep Apnea and Obesity 513 A Mixed-methods Exploration of Patient Perspectives on Pap Therapy Initiation: Implications for Improved Outreach and Education 514 Comparative Effectiveness of Biologic Therapy Versus Antifungal Therapy for Allergic Bronchopulmonary Aspergillosis 515 Rethinking Missing Data Handling in Crisis Standards of Care Simulations: A Retrospective Simulation Study 516 Integrating Tobacco Treatment into Lung Cancer Screening: A Qualitative Assessment 517 Using a Natural Language Processing System to Identify Computed Tomography Chest Scan Reports With Recommended Follow-up 518 Improved Lung Cancer Screening Outcomes Through Blood-Based Genomic Testing: Population and Payer Impact 519 Patient Perceived Barriers and Facilitators in Improving Health Related Quality of Life (HRQOL) in Patients Living With Hypersensitivity Pneumonitis 520 Grit and Resilience Among Pulmonary and Critical Care Medicine Physicians: A Multi-institutional Study 521 ChatGPT Generates Appropriate Assessments and

522 Advancements in Primary Ciliary Dyskinesia Diagnosis: Impact of Establishment of a PCD Center in Puerto Rico (2008-2023) 523 Barriers and Facilitators to Discussing Lung Transplantation Among Individuals With Cystic Fibrosis in the Era of Highly Effective Modulators 524 Lymphangioleiomyomatosis Patient Research Priorities Survey (LAM-PREP): Developing Patient-Centered Research Agenda 525 E-cigarette Use, Marijuana Use, and Depressive Symptoms in Young Adults: The VapeScan Study

CLINICAL POSTER DISCUSSION SESSION

D103 BE PREPARED! RARE

PRESENTATIONS AND TREATMENTS IN THE ICU

11:00 a.m. - 1:00 p.m.

San Diego Convention Center Room 30C-E (Upper Level)

Poster Viewing

11:00-11:45

Discussion 11:45-1:00 701 Calcium Channel Overdose and Insulin Therapy Dosing 702 Chagas Disease: A Hidden Cause of Sudden Cardiac Arrest 703 Dying From the Diet: A Case of 2,4-dinitrophenol Toxicity 704 Lipemic Serum and Severe Acute Pancreatitis 705 Bone Cement Implantation Syndrome: An Unusual Cardiogenic Complication in an Elderly Patient With Spinal Injury 706 A Rare Case of Neurofibromatosis Type I Presenting as Internal Mammary Artery Aneurysmal Rupture 707 More Than What Meets the Eye: A Case of Fulminant Malaria in the Intensive Care Unit 708 Surviving the Storm: A Race Against Time in Treating Post-partum Streptococcal Toxic Shock Syndrome

Plans for Patients Evaluated in the Emergency Room With Suspected Community-Acquired Pneumonia (CAP)

ATS 2024 • San Diego, CA